Science News
from research organizations

Alzheimer's detected before symptoms via new eye technology

Date:
July 11, 2016
Source:
Association for Research in Vision and Ophthalmology (ARVO)
Summary:
Scientists may have overcome a major roadblock in the development of Alzheimer's therapies by creating a new technology to observe in the back of the eye progression of the disease before the onset of symptoms. Clinical trials are starting soon to test the technology in humans, according to a new paper.
Share:
FULL STORY

Scientists may have overcome a major roadblock in the development of Alzheimer's therapies by creating a new technology to observe -- in the back of the eye -- progression of the disease before the onset of symptoms.
Credit: © ibreakstock / Fotolia

Scientists may have overcome a major roadblock in the development of Alzheimer's therapies by creating a new technology to observe ― in the back of the eye ― progression of the disease before the onset of symptoms. Clinical trials are to start in July to test the technology in humans according to a paper recently published in Investigative Ophthalmology & Visual Science (IOVS).

The paper, titled "Early detection of amyloidopathy in Alzheimer's mice by hyperspectral endoscopy," builds upon previous work in cells by detecting changes in the retina of mice predisposed to develop Alzheimer's.

Early detection of Alzheimer's is critical for two reasons. "First, effective treatments need to be administered well before patients show actual neurological signs," said author Robert Vince, PhD, of the Center for Drug Design at the University of Minnesota (UMN). "Second, since there are no available early detection techniques, drugs currently cannot be tested to determine if they are effective against early Alzheimer's disease. An early diagnostic tool like ours could help the development of drugs as well."

Looking through the eye to see the brain is a key advantage of the new technology. "The retina of the eye is not just 'connected' to the brain -- it is part of the central nervous system," said author Swati More, PhD, also of the Center for Drug Design at UMN. While the brain and retina undergo similar changes due to Alzheimer's disease, "unlike the brain, the retina is easily accessible to us, making changes in the retina easier to observe."

"We saw changes in the retinas of Alzheimer's mice before the typical age at which neurological signs are observed," said More. "The results are close to our best-case scenario for outcomes of this project."


Story Source:

Materials provided by Association for Research in Vision and Ophthalmology (ARVO). Note: Content may be edited for style and length.


Journal Reference:

  1. Swati S. More, James M. Beach, Robert Vince. Early Detection of Amyloidopathy in Alzheimer's Mice by Hyperspectral Endoscopy. Investigative Opthalmology & Visual Science, 2016; 57 (7): 3231 DOI: 10.1167/iovs.15-17406

Cite This Page:

Association for Research in Vision and Ophthalmology (ARVO). "Alzheimer's detected before symptoms via new eye technology." ScienceDaily. ScienceDaily, 11 July 2016. <www.sciencedaily.com/releases/2016/07/160711151708.htm>.
Association for Research in Vision and Ophthalmology (ARVO). (2016, July 11). Alzheimer's detected before symptoms via new eye technology. ScienceDaily. Retrieved April 25, 2017 from www.sciencedaily.com/releases/2016/07/160711151708.htm
Association for Research in Vision and Ophthalmology (ARVO). "Alzheimer's detected before symptoms via new eye technology." ScienceDaily. www.sciencedaily.com/releases/2016/07/160711151708.htm (accessed April 25, 2017).